Last reviewed · How we verify
BCMA CAR-NK 92 cells
At a glance
| Generic name | BCMA CAR-NK 92 cells |
|---|---|
| Sponsor | Asclepius Technology Company Group (Suzhou) Co., Ltd. |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- BCMA CAR-NK 92 cells CI brief — competitive landscape report
- BCMA CAR-NK 92 cells updates RSS · CI watch RSS
- Asclepius Technology Company Group (Suzhou) Co., Ltd. portfolio CI